SGLT-2 inhibitors and the risk of migraine in patients with type 2 diabetes mellitus: a population-based target trial emulation studyAuthorsXingkai An (ORCID: https://orcid.org/0000-0003-1842-6387)Jingyuan Zheng (ORCID: https://orcid.org/0009-0009-6139-3614)Jiedong ZhaoJielong Wu (ORCID: https://orcid.org/0000-0001-9142-2871)Jie Fang (ORCID: https://orcid.org/0000-0003-1526-7851)QiLin MaZiJuan GuoHuaiPeng YangXiaodong YuanYihan WangLiangcheng ZhengInstitutionsFujian University of Traditional Chinese Medicine (CN)Xiamen University (CN)First Affiliated Hospital of Xiamen University (CN)Xiamen Maternal and Child Health Hospital (CN)Publication DetailsJournalThe Journal of Headache and PainPublished2026-10-17DOIhttps://doi.org/10.1186/s10194-026-02546-1Primary TopicMigraine and Headache StudiesTypearticleField-Weighted Citation Impact0.00Explore the Global Research Space Interactive Map